Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory) General Information

Description

U.S. and Canadian rights to Ponvory.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • United States
Primary Industry
Buildings and Property
Corporate Office
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory)‘s full profile, request access.

Request a free trial

Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory)‘s full profile, request access.

Request a free trial

Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory) FAQs

  • Where is Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory) headquartered?

    Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory) is headquartered in .

  • What industry is Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory) in?

    Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory)’s primary industry is Buildings and Property.

  • Is Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory) a private or public company?

    Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory) is a Private company.

  • What is the current valuation of Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory)?

    The current valuation of Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory) is .

  • What is Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory)’s current revenue?

    The current revenue for Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory) is .

  • Who are Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory)’s investors?

    Actelion Pharmaceuticals has invested in Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory).

  • When was Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory) acquired?

    Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory) was acquired on 07-Dec-2023.

  • Who acquired Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory)?

    Actelion Pharmaceuticals (United States and Canadian Rights to Ponvory) was acquired by Vanda Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process